赛诺医疗收盘下跌1.75%，滚动市盈率724.36倍，总市值44.48亿元

Core Viewpoint - Sino Medical reported a closing price of 10.69 yuan, down 1.75%, with a rolling PE ratio of 724.36 times, and a total market value of 4.448 billion yuan [1] Company Summary - Sino Medical's main business focuses on the research, development, production, and sales of high-end interventional medical devices [1] - Key products include biodegradable drug-coated coronary stent systems, drug-eluting stent systems, non-compliant PTCA balloon dilatation catheters, and various other specialized medical devices [1] Financial Performance - For Q1 2025, the company achieved an operating income of 101 million yuan, representing a year-on-year increase of 10.75% [2] - The net profit for the same period was 2.9693 million yuan, showing a significant year-on-year increase of 277.50% [2] - The sales gross margin stood at 59.66% [2] Industry Comparison - The average PE ratio for the medical device industry is 49.45 times, with a median of 35.92 times, positioning Sino Medical at 121st place within the industry [1] - The company's static PE ratio is 296.94 times, and the price-to-book ratio is 5.11 [2]